Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Imperial College London · Hôpital Privé Jacques Cartier · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
536
total citations
- FWCI
- 100.18
- Percentile
- 100%
- References
- 30
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- Medicine
- Everolimus
- Clinical endpoint
- Stent
- Clinical trial
- Vasomotion
- Internal medicine
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.